Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06310161 · ClinicalTrials.gov registry record · NA

Light Therapy in End Stage Kidney Disease

A NA study of End Stage Renal Disease, sponsored by University of Pennsylvania.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT06310161 is a NA study of End Stage Renal Disease that is actively recruiting participants, run by University of Pennsylvania. The registered enrollment target is 60 participants, below the 833-participant average among 86 other End Stage Renal Disease trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06310161, a NA study of End Stage Renal Disease, is actively recruiting participants, sponsored by University of Pennsylvania.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical trial is to test light therapy in patients with end stage kidney disease who are receiving hemodialysis. The main aim is to determine if light therapy decreases fatigue severity. Participants will receive light therapy using special glasses for one hour during the dialysis sessions for four weeks of treatment.

Conditions Studied

End Stage Renal Disease

Interventions

  • DEVICE Bright light
  • DEVICE Dim Light

Study Locations (1)

Pennsylvania

  • University of Pennsylvania - Philadelphia

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2026-02-01
Est. Completion 2026-08-01
Phase NA

Sponsor

University of Pennsylvania

1,423 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06310161

The ClinicalTrials.gov registry entry for NCT06310161 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 833-participant average among 86 other End Stage Renal Disease trials with a reported enrollment target (93% lower). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with End Stage Renal Disease appearing as the primary indexed condition, and to 2 interventions - of which Bright light is the first listed.

NCT06310161 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT06310161 about?

NCT06310161 is a clinical study titled "Light Therapy in End Stage Kidney Disease". The goal of this clinical trial is to test light therapy in patients with end stage kidney disease who are receiving hemodialysis. The main aim is to determine if light therapy decreases fatigue severity. Participants will receive light therapy using special glasses for one hour during the dialysis ...

What is the current status of trial NCT06310161?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2026-02-01. Estimated completion is 2026-08-01.

What conditions does trial NCT06310161 study?

This clinical trial studies the following conditions: End Stage Renal Disease.

What interventions are being tested in trial NCT06310161?

The interventions under investigation include: Bright light (DEVICE), Dim Light (DEVICE).

Who is sponsoring clinical trial NCT06310161?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06310161 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for End Stage Renal Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

End Stage Renal Disease

All registered trials for this condition

Pennsylvania

All trials with a study site in Pennsylvania

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.